Analysis of [3′,3′-d2]-nicotine and [3′,3′-d2]-cotinine by capillary liquid chromatography–electrospray tandem mass spectrometry
Authors:
- P VillaltaPVP Villalta
- S HoSHS Ho
- L VonweymarnLVL Vonweymarn
- 15 September 2007
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 857 (1) , 1-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Specific Detection of Anabasine, Nicotine, and Nicotine Metabolites in Urine by Liquid Chromatography–Tandem Mass SpectrometryAmerican Journal of Clinical Pathology, 2006
- CYP2A6 genotype and the metabolism and disposition kinetics of nicotineClinical Pharmacology & Therapeutics, 2006
- Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearanceClinical Pharmacology & Therapeutics, 2006
- Trends in the Exposure of Nonsmokers in the U.S. Population to Secondhand Smoke: 1988–2002Environmental Health Perspectives, 2006
- Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessationClinical Pharmacology & Therapeutics, 2006
- Inactivation of CYP2A6 and CYP2A13 during Nicotine MetabolismThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography–electrospray tandem mass spectrometric (HILIC–ESI/MS/MS) bioanalysis of basic compoundsJournal of Chromatography B, 2005
- Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence*Clinical Pharmacology & Therapeutics, 2005
- Metabolism and Disposition Kinetics of NicotinePharmacological Reviews, 2005
- Simultaneous and Sensitive Measurement of Anabasine, Nicotine, and Nicotine Metabolites in Human Urine by Liquid Chromatography–Tandem Mass SpectrometryClinical Chemistry, 2004